Marshall Islands vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB
Marshall Islands
100.0%
in 2024
Western Pacific (WHO region)
86.0%
in 2024
Marshall Islands rank
1st
Western Pacific (WHO region) rank
3rd
Previously treated cases tested for RR-/MDR-TB over time
- Marshall Islands
- Western Pacific (WHO region)
How they compare
Marshall Islands currently reports 100.0% against 86.0% in Western Pacific (WHO region), a difference of 14.0%.
That makes Marshall Islands's figure about 1.2 times Western Pacific (WHO region)'s.
The two have swapped places 6 times across 19 shared years of data; in 2005 it was Marshall Islands ahead.
Marshall Islands ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
Across the 3 decades both report, Marshall Islands averaged higher in 2 and Western Pacific (WHO region) in 1.
Head to head by decade
| Decade | Marshall Islands | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 54.5% | 0.9% | 53.6% | Marshall Islands |
| 2010s | 40.9% | 54.9% | 14.0% | Western Pacific (WHO region) |
| 2020s | 100.0% | 89.2% | 10.8% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Marshall Islands or Western Pacific (WHO region)?
- Marshall Islands, at 100.0% against 86.0% in Western Pacific (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Marshall Islands and Western Pacific (WHO region)?
- 14.0%, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Western Pacific (WHO region)?
- 19 years are reported by both, from 2005 to 2024.
- How do Marshall Islands and Western Pacific (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Marshall Islands ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.